Semmelweis University Heart and Vascular Centre Established as Imricor’s Eleventh iCMR Site

13 October 2021 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in iCMR-guided cardiac ablation products, is pleased to announce that the Semmelweis University Heart and Vascular Centre in Budapest Hungary, has signed a purchase agreement with Imricor, making it the eleventh site to establish an iCMR lab to perform ablations with Imricor’s products.

The site is planning to begin procedures before the end of 2021 in an existing Cardiovascular Magnetic Resonance (CMR) suite that will be outfitted to be an iCMR lab.

Dr. Béla Merkely, who received the Széchenyi Prize this year, honoring the greatest scientists in Hungary alive today, is leading the iCMR program. 

Imricor’s Chair and CEO, Steve Wedan, said: “We are very pleased to add the Heart and Vascular Centre of Semmelweis University to our roster of prestigious medical centers leading the way with iCMR ablations.

“Expansion into Hungary marks a significant milestone for Imricor. We look forward to working with the team at Semmelweis University to offer iCMR ablations to their patients,” said Greg Englehardt, Imricor’s Executive Director of Sales.

~ ~ ~ ~ ~
About Imricor